Fan Y, Wang D, Rao C, Li Y, Rong H, Wang Z, et al. Atorvastatin combined with low-dose Dexamethasone Treatment protects endothelial function impaired by chronic subdural hematoma via the transcription factor KLF-2. Drug Des Devel Ther. 2020;14:3291–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holl DC, Volovici V, Dirven CMF, Peul WC, van Kooten F, Jellema K, et al. Pathophysiology and nonsurgical treatment of chronic subdural hematoma: from past to Present to Future. World Neurosurg. 2018;116:402–11e2.

Article  PubMed  Google Scholar 

Li T, Wang D, Tian Y, Yu H, Wang Y, Quan W, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats. J Neurol Sci. 2014;341(1–2):88–96.

Article  CAS  PubMed  Google Scholar 

Wang D, Li T, Wei H, Wang Y, Yang G, Tian Y, et al. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model. J Neurol Sci. 2016;362:91–9.

Article  CAS  PubMed  Google Scholar 

Jack A, O’Kelly C, McDougall C, Findlay JM. Predicting recurrence after chronic subdural haematoma drainage. Can J Neurol Sci. 2015;42(1):34–9.

Article  PubMed  Google Scholar 

Mori K, Maeda M. Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, Complications, and recurrence rate. Neurol Med Chir (Tokyo). 2001;41(8):371–81.

Article  CAS  PubMed  Google Scholar 

Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg. 2001;95(2):256–62.

Article  CAS  PubMed  Google Scholar 

Ramachandran R, Hegde T. Chronic subdural hematomas–causes of morbidity and mortality. Surg Neurol. 2007;67(4):367–72. discussion 72 – 3.

Article  PubMed  Google Scholar 

Yamamoto H, Hirashima Y, Hamada H, Hayashi N, Origasa H, Endo S. Independent predictors of recurrence of chronic subdural hematoma: results of multivariate analysis performed using a logistic regression model. J Neurosurg. 2003;98(6):1217–21.

Article  PubMed  Google Scholar 

Ironside N, Nguyen C, Do Q, Ugiliweneza B, Chen CJ, Sieg EP, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis. J Neurointerv Surg. 2021;13(10):951–7.

Article  PubMed  Google Scholar 

Srivatsan A, Mohanty A, Nascimento FA, Hafeez MU, Srinivasan VM, Thomas A, et al. Middle meningeal artery embolization for chronic subdural hematoma: Meta-Analysis and systematic review. World Neurosurg. 2019;122:613–9.

Article  PubMed  Google Scholar 

Chan DY, Chan DT, Sun TF, Ng SC, Wong GK, Poon WS. The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study(). Br J Neurosurg. 2017;31(1):72–7.

Article  PubMed  Google Scholar 

Guidry BS, Kelly KA, Yengo-Kahn AM, Lan M, Tang AR, Chotai S, et al. Statins as a medical Adjunct in the Surgical Management of Chronic Subdural hematomas. World Neurosurg. 2021;149:e281–e91.

Article  PubMed  PubMed Central  Google Scholar 

He C, Xia P, Xu J, Chen L, Zhang Q. Evaluation of the efficacy of atorvastatin in the treatment for chronic subdural hematoma: a meta-analysis. Neurosurg Rev. 2021;44(1):479–84.

Article  PubMed  Google Scholar 

Huang J, Gao C, Dong J, Zhang J, Jiang R. Drug treatment of chronic subdural hematoma. Expert Opin Pharmacother. 2020;21(4):435–44.

Article  PubMed  Google Scholar 

Jiang R, Zhao S, Wang R, Feng H, Zhang J, Li X, et al. Safety and efficacy of atorvastatin for chronic subdural hematoma in Chinese patients: a Randomized ClinicalTrial. JAMA Neurol. 2018;75(11):1338–46.

Article  PubMed  PubMed Central  Google Scholar 

Klein J, Mauck L, Schackert G, Pinzer T. Do statins reduce the rate of revision Surgery after chronic subdural hematoma drain? Acta Neurochir (Wien). 2021;163(7):1843–8.

Article  PubMed  Google Scholar 

Tang R, Shi J, Li X, Zou Y, Wang L, Chen Y, et al. Effects of Atorvastatin on Surgical treatments of chronic subdural hematoma. World Neurosurg. 2018;117:e425–e9.

Article  PubMed  Google Scholar 

Qiu S, Zhuo W, Sun C, Su Z, Yan A, Shen L. Effects of atorvastatin on chronic subdural hematoma: a systematic review. Med (Baltim). 2017;96(26):e7290.

Article  CAS  Google Scholar 

Xu M, Chen P, Zhu X, Wang C, Shi X, Yu B. Effects of Atorvastatin on Conservative and Surgical treatments of chronic subdural hematoma in patients. World Neurosurg. 2016;91:23–8.

Article  PubMed  Google Scholar 

Potey C, Ouk T, Petrault O, Petrault M, Berezowski V, Salleron J, et al. Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia. Br J Pharmacol. 2015;172(21):5188–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araujo FA, Rocha MA, Mendes JB, Andrade SP. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother. 2010;64(1):29–34.

Article  CAS  PubMed  Google Scholar 

Buttmann M, Lorenz A, Weishaupt A, Rieckmann P. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. J Neurochem. 2007;102(4):1001–8.

Article  CAS  PubMed  Google Scholar 

Liu Y, Wei J, Hu L, Hu S. Beneficial effects of statins on endothelial progenitor cells. Am J Med Sci. 2012;344(3):220–6.

Article  PubMed  Google Scholar 

Sobrino T, Blanco M, Perez-Mato M, Rodriguez-Yanez M, Castillo J. Increased levels of circulating endothelial progenitor cells in patients with ischaemic Stroke treated with statins during acute phase. Eur J Neurol. 2012;19(12):1539–46.

Article  CAS  PubMed  Google Scholar 

Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet. 2009;374(9695):1067–73.

Article  PubMed  Google Scholar 

Liu WC, Lin QQ, Jin J, Wang M, You WD, Gu J, et al. An association of low high-density lipoprotein levels with recurrence of chronic subdural hematoma. Acta Neurochir (Wien). 2021;163(4):1061–8.

Article  PubMed  Google Scholar 

Othman RA, Myrie SB, Mymin D, Roullet JB, Steiner RD, Jones PJH. Effect of ezetimibe on low- and high-density lipoprotein subclasses in sitosterolemia. Atherosclerosis. 2017;260:27–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McTaggart F, Jones P. Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit. Cardiovasc Drugs Ther. 2008;22(4):321–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barker G, Winer JR, Guirgis FW, Reddy S. HDL and persistent inflammation immunosuppression and catabolism syndrome. Curr Opin Lipidol. 2021;32(5):315–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grao-Cruces E, Lopez-Enriquez S, Martin ME, Montserrat-de la Paz S. High-density lipoproteins and immune response: a review. Int J Biol Macromol. 2022;195:117–23.

Article  CAS  PubMed  Google Scholar 

Weigel R, Hohenstein A, Schilling L. Vascular endothelial growth factor concentration in chronic subdural hematoma fluid is related to computed tomography appearance and exudation rate. J Neurotrauma. 2014;31(7):670–3.

Article  PubMed  PubMed Central  Google Scholar 

Petrov A, Ivanov A, Dryagina N, Petrova A, Samochernykh K, Rozhchenko L. Angiogenetic factors in chronic subdural Hematoma Development. Diagnostics (Basel). 2022;12(11).

Sahebkar A, Ponziani MC, Goitre I, Bo S. Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials. Metabolism. 2015;64(11):1466–76.

Article  CAS  PubMed  Google Scholar 

Tan JT, Ng MK, Bursill CA. The role of high-density lipoproteins in the regulation of angiogenesis. Cardiovasc Res. 2015;106(2):184–93.

Article  CAS  PubMed  Google Scholar 

Jin F, Hagemann N, Sun L, Wu J, Doeppner TR, Dai Y, et al. High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation. Angiogenesis. 2018;21(2):381–94.

Article  CAS  PubMed  Google Scholar